Paediatrics (RCH) - Research Publications
Permanent URI for this collection
Search Results
1 - 7 of 7
-
ItemFrench Intensive Care Society, International congress - Réanimation 2016.(Springer Science and Business Media LLC, 2016-06)
-
ItemNo Preview AvailableDisease Spectrum and Management of Children Admitted with Acute Respiratory Infection in Viet Nam(Wiley, 2017-11-23)Background: Acute respiratory infection (ARI) is the most common reason for admission to paediatric wards in Viet Nam, being responsible for 39.9% of hospital admissions and 7.9% of hospital deaths in southern Viet Nam. However, few studies have explored the ARI disease spectrum observed in central Viet Nam or differences between primary (district), secondary (provincial) and tertiary (national) level hospitals. Aims: To assess the acute respiratory infection (ARI) disease spectrum, duration of hospitalisation and outcome in children hospitalised with an ARI in Viet Nam. Methods: We conducted a retrospective descriptive study of ARI admissions to primary (Hoa Vang District Hospital), secondary (Da Nang Hospital for Women and Children) and tertiary (National Hospital of Paediatrics in Ha Noi) level hospitals in Viet Nam over a 12-month period(01/09/2015 to 31/08/2016). Results: ARIs accounted for 27.9% (37,436 / 134,061) of all paediatric admissions; nearly half (47.6%) of all children admitted to Hoa Vang District Hospital. Most (64.6%) children hospitalised with an ARI were<2 years of age. Influenza/pneumonia accounted for 69.4% of admissions; tuberculosis for only 0.3%. Overall 284 (0.8%) children died; most deaths (269/284; 94.7%) occurred at the tertiary referral hospital. The average duration of hospitalization was 7.6 days (median 7 days). The average direct hospitalization cost per ARI admission was 157.5 USD in Da Nang Provincial Hospital. In total, 62.6% of admissions were covered by health insurance. Conclusions: ARI is a major cause of paediatric hospitalization in Viet Nam, characterized by prolonged hospitalization for relatively mild disease. There is huge potential to reduce unnecessary hospital admission and cost.
-
Item
-
ItemNo Preview AvailableBIOACTIVITY IN AN AGGRECAN 32MER FRAGMENT IS MEDIATED VIA TOLL-LIKE RECEPTORS(ELSEVIER SCI LTD, 2014-04-01)
-
ItemNo Preview AvailableAN OPEN LABEL CLINICAL PILOT STUDY OF RESVERATROL AS A TREATMENT FOR FRIEDREICH ATAXIA(WILEY-BLACKWELL, 2013-06-01)
-
ItemPopulation Response To Change In Infant Feeding Guidelines For Allergy Prevention(MOSBY-ELSEVIER, 2014-02-01)
-
ItemMeningitis in children in Fiji: etiology, epidemiology and neurological sequeale(ELSEVIER SCI LTD, 2012-06-01)